When structural sophistication becomes a translational barrier: the complexity trap in DNA nanocarrier design.

Authors

Cansu Umran Tunc, Sushanto Kumar Saha, Siva S Panda, Shogo Mori, Mustafa Culha

Published in

Nanomedicine (London, England). Pages 1-15. Nov 03, 2026. Epub Nov 03, 2026.

Abstract

DNA nanotechnology has emerged as a highly programmable platform in nanomedicine, enabling the fabrication of precise nanoscale architectures for drug delivery, biosensing, gene regulation, immunotherapy, and theranostics. DNA-based nanocarriers offer distinctive advantages, including structural programmability, molecular recognition, multifunctionality, biocompatibility, and stimuli responsiveness. These capabilities have driven the development of DNA origami, tetrahedra, nanocages, hydrogels, aptamer-based systems, and dynamic nanomachines for biomedical applications. Despite compelling proof-of-concept demonstrations and promising preclinical studies, however, clinical translation remains limited. Key barriers include nuclease-mediated instability, immune recognition, biomolecular corona formation, endosomal trapping, unfavorable biodistribution, manufacturing complexity, scalability limitations, regulatory uncertainty, and high production costs. Moreover, the field remains largely driven by engineering innovation and structural sophistication rather than translational practicality. This Perspective critically examines the structural, engineering, and biological barriers restricting the development of DNA nanocarriers into clinically viable systems, while briefly addressing regulatory and commercialization challenges. Emerging strategies, including chemical stabilization, hybrid and biomimetic platforms, AI-assisted optimization, and simplified nanostructure designs, are discussed in the context of overcoming these barriers. We argue that successful clinical translation will require a shift from complexity-driven nanoscale engineering toward clinically oriented platforms that are biologically robust, scalable, manufacturable, and economically sustainable.

PMID:
42975255
Bibliographic data and abstract were imported from PubMed on 03 Nov 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.